Lifecore Biomedical Inc（LFCR）價格預測LFCRLifecore Biomedical Inc

Alphio's LFCR stock price prediction model matches the current Lifecore Biomedical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.34 (-1.17%). The 1-week path is $4.50 (+2.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Lifecore Biomedical Inc (LFCR) is currently priced at $4.54, which is below the analyst price target of $6.25, indicating potential upside. However, the stock has a low RSI of 44.54, suggesting it is not in an overbought condition, but it also reflects a lack of momentum. The company has reported a significant year-to-date decline of 41.34% and a net loss of $7.1 million in Q2 2026, which raises concerns about its profitability. The main risk is the high debt-to-equity ratio of 963.57%, indicating potential financial instability. Therefore, while there is a possibility for recovery, the current risks suggest holding rather than buying.

Lifecore Biomedical Inc (LFCR) last closed at $4.39, gaining +0.92%. These facts feed the 1-day and 1-week LFCR price prediction above.